Search

Search Constraints

You searched for: Author/Creator Quinn, Marie

Search Results

2. 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer. (9th November 2020)

3. 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer. (9th November 2020)

7. Surveillance of Probably Benign (BI‐RADS 3) Lesions in Mammography: What Is The Right Follow‐Up Protocol?. Issue 2 (9th February 2015)